Our clients come back, because of the way we work.

All we do, we do with our heart.

At IXtlamatia we believe that our people are the most important asset. they who have helped to make IXtlamatia the success it is. Their commitment to clients, quality and delivery has earned IXtlamatia its enviable reputation.
Our goal is to provide exceptional services to complete our clients' clinical trials. These services include clinical research, Biostatistics & Data Management and consulting services.
Our commitment to you is to produce quality data to agreed timelines with expertise, flexibility and to your total satisfaction.

IXtlamatia Clinical Research / Service Overview 
IXtlamatia Clinical Research specializes in the planning management, execution and analysis of Phase I – IV clinical trials, ranging from small studies to complex, multinational projects.

Experience you can trust 
IXtlamatia Clinical Research professionals apply their therapeutic, regulatory and operational expertise to consistently solve the challenges that arise during all clinical projects. Our core competency is project management underpinned by comprehensive and consistent processes which conform to ISO9001:2000 and a culture that is focused on delivering quality information to clients.

IXtlamatia Clinical Research has conducted clinical studies involving many patients in different centers across Latin America, in all major therapeutic areas including CNS, Oncology, Cardiology, Transplant, Dermatology, Metabolic and Gastroenterology, Endocrinology, Infectious Diseases, Pain Management, Pediatrics, Respiratory, and Urology..

Excellence in Delivery 
We place the highest importance on delivering quality data on time and on budget. Performance is monitored regularly and measured against contractual timelines. Project costs are measured per month on a project-by-project basis to ensure adherence to agreed budgets. Our primary approach is to use dedicated teams to achieve optimum results, but we can implement a range of resourcing models to suit client requirements

Individual services, global impact 
IXtlamatia is a leading global clinical research organization providing the full range of early– to late–stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide.

As one of the fastest-growing global providers of Phase I-IV services we offer experience spanning 20 countries in Latin America, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

IXtlamatia has a history of serving customers, both large and small, and with a diversity of compounds, which means that our expertise spans every major therapeutic area. We have focused our therapeutic offerings on market needs and are already aligned with the top areas